TOKUNAGA, Ryuma; ZHANG, Wu; NASEEM, Madiha. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy. Cancer Treatment Reviews. 2018-2, roč. 63, s. 40–47. Dostupné online [cit. 2019-04-30]. doi:10.1016/j.ctrv.2017.11.007. PMID29207310. (anglicky)
SCHOENBORN, Jamie R.; WILSON, Christopher B. Regulation of Interferon‐γ During Innate and Adaptive Immune Responses. Svazek 96. [s.l.]: Elsevier Dostupné online. ISBN9780123737090. doi:10.1016/s0065-2776(07)96002-2. S. 41–101. (anglicky) DOI: 10.1016/S0065-2776(07)96002-2.
FERNANDEZ-POMA, Sarita M.; SALAS-BENITO, Diego; LOZANO, Teresa. Expansion of Tumor-Infiltrating CD8 + T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy. Cancer Research. 2017-07-01, roč. 77, čís. 13, s. 3672–3684. Dostupné online [cit. 2019-04-30]. ISSN0008-5472. doi:10.1158/0008-5472.CAN-17-0236. (anglicky)
ZHU, Guiquan; YAN, H. Hannah; PANG, Yanli. CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity. Oncotarget. 2015-12-22, roč. 6, čís. 41. Dostupné online [cit. 2019-04-30]. ISSN1949-2553. doi:10.18632/oncotarget.6125. PMID26485767. (anglicky)
GORBACHEV, A. V.; KOBAYASHI, H.; KUDO, D. CXC Chemokine Ligand 9/Monokine Induced by IFN- Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors. The Journal of Immunology. 2007-02-15, roč. 178, čís. 4, s. 2278–2286. Dostupné online [cit. 2019-04-30]. ISSN0022-1767. doi:10.4049/jimmunol.178.4.2278. (anglicky)
ZOHAR, Yaniv; WILDBAUM, Gizi; NOVAK, Rostislav. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. Journal of Clinical Investigation. 2014-05-01, roč. 124, čís. 5, s. 2009–2022. Dostupné online [cit. 2019-04-30]. ISSN0021-9738. doi:10.1172/JCI71951. PMID24713654. (anglicky)
OGHUMU, Steve; VARIKUTI, Sanjay; TERRAZAS, Cesar. CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. Immunology. 2014-9, roč. 143, čís. 1, s. 109–119. Dostupné online [cit. 2019-04-30]. doi:10.1111/imm.12293. PMID24679047. (anglicky)
MOSSER, David M.; EDWARDS, Justin P. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 2008-12, roč. 8, čís. 12, s. 958–969. Dostupné online [cit. 2019-04-30]. ISSN1474-1733. doi:10.1038/nri2448. PMID19029990. (anglicky)
BEDOGNETTI, D; SPIVEY, T L; ZHAO, Y. CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. British Journal of Cancer. 2013-10, roč. 109, čís. 9, s. 2412–2423. Dostupné online [cit. 2019-04-30]. ISSN0007-0920. doi:10.1038/bjc.2013.557. PMID24129241. (anglicky)
elsevier.com
linkinghub.elsevier.com
TOKUNAGA, Ryuma; ZHANG, Wu; NASEEM, Madiha. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy. Cancer Treatment Reviews. 2018-2, roč. 63, s. 40–47. Dostupné online [cit. 2019-04-30]. doi:10.1016/j.ctrv.2017.11.007. PMID29207310. (anglicky)
SCHOENBORN, Jamie R.; WILSON, Christopher B. Regulation of Interferon‐γ During Innate and Adaptive Immune Responses. Svazek 96. [s.l.]: Elsevier Dostupné online. ISBN9780123737090. doi:10.1016/s0065-2776(07)96002-2. S. 41–101. (anglicky) DOI: 10.1016/S0065-2776(07)96002-2.
jci.org
ZOHAR, Yaniv; WILDBAUM, Gizi; NOVAK, Rostislav. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. Journal of Clinical Investigation. 2014-05-01, roč. 124, čís. 5, s. 2009–2022. Dostupné online [cit. 2019-04-30]. ISSN0021-9738. doi:10.1172/JCI71951. PMID24713654. (anglicky)
jimmunol.org
GORBACHEV, A. V.; KOBAYASHI, H.; KUDO, D. CXC Chemokine Ligand 9/Monokine Induced by IFN- Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors. The Journal of Immunology. 2007-02-15, roč. 178, čís. 4, s. 2278–2286. Dostupné online [cit. 2019-04-30]. ISSN0022-1767. doi:10.4049/jimmunol.178.4.2278. (anglicky)
nature.com
MOSSER, David M.; EDWARDS, Justin P. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 2008-12, roč. 8, čís. 12, s. 958–969. Dostupné online [cit. 2019-04-30]. ISSN1474-1733. doi:10.1038/nri2448. PMID19029990. (anglicky)
BEDOGNETTI, D; SPIVEY, T L; ZHAO, Y. CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. British Journal of Cancer. 2013-10, roč. 109, čís. 9, s. 2412–2423. Dostupné online [cit. 2019-04-30]. ISSN0007-0920. doi:10.1038/bjc.2013.557. PMID24129241. (anglicky)
nih.gov
ncbi.nlm.nih.gov
TOKUNAGA, Ryuma; ZHANG, Wu; NASEEM, Madiha. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy. Cancer Treatment Reviews. 2018-2, roč. 63, s. 40–47. Dostupné online [cit. 2019-04-30]. doi:10.1016/j.ctrv.2017.11.007. PMID29207310. (anglicky)
ZHU, Guiquan; YAN, H. Hannah; PANG, Yanli. CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity. Oncotarget. 2015-12-22, roč. 6, čís. 41. Dostupné online [cit. 2019-04-30]. ISSN1949-2553. doi:10.18632/oncotarget.6125. PMID26485767. (anglicky)
ZOHAR, Yaniv; WILDBAUM, Gizi; NOVAK, Rostislav. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. Journal of Clinical Investigation. 2014-05-01, roč. 124, čís. 5, s. 2009–2022. Dostupné online [cit. 2019-04-30]. ISSN0021-9738. doi:10.1172/JCI71951. PMID24713654. (anglicky)
OGHUMU, Steve; VARIKUTI, Sanjay; TERRAZAS, Cesar. CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. Immunology. 2014-9, roč. 143, čís. 1, s. 109–119. Dostupné online [cit. 2019-04-30]. doi:10.1111/imm.12293. PMID24679047. (anglicky)
MOSSER, David M.; EDWARDS, Justin P. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 2008-12, roč. 8, čís. 12, s. 958–969. Dostupné online [cit. 2019-04-30]. ISSN1474-1733. doi:10.1038/nri2448. PMID19029990. (anglicky)
BEDOGNETTI, D; SPIVEY, T L; ZHAO, Y. CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. British Journal of Cancer. 2013-10, roč. 109, čís. 9, s. 2412–2423. Dostupné online [cit. 2019-04-30]. ISSN0007-0920. doi:10.1038/bjc.2013.557. PMID24129241. (anglicky)
oncotarget.com
ZHU, Guiquan; YAN, H. Hannah; PANG, Yanli. CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity. Oncotarget. 2015-12-22, roč. 6, čís. 41. Dostupné online [cit. 2019-04-30]. ISSN1949-2553. doi:10.18632/oncotarget.6125. PMID26485767. (anglicky)
wiley.com
doi.wiley.com
OGHUMU, Steve; VARIKUTI, Sanjay; TERRAZAS, Cesar. CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. Immunology. 2014-9, roč. 143, čís. 1, s. 109–119. Dostupné online [cit. 2019-04-30]. doi:10.1111/imm.12293. PMID24679047. (anglicky)
worldcat.org
FERNANDEZ-POMA, Sarita M.; SALAS-BENITO, Diego; LOZANO, Teresa. Expansion of Tumor-Infiltrating CD8 + T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy. Cancer Research. 2017-07-01, roč. 77, čís. 13, s. 3672–3684. Dostupné online [cit. 2019-04-30]. ISSN0008-5472. doi:10.1158/0008-5472.CAN-17-0236. (anglicky)
ZHU, Guiquan; YAN, H. Hannah; PANG, Yanli. CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity. Oncotarget. 2015-12-22, roč. 6, čís. 41. Dostupné online [cit. 2019-04-30]. ISSN1949-2553. doi:10.18632/oncotarget.6125. PMID26485767. (anglicky)
GORBACHEV, A. V.; KOBAYASHI, H.; KUDO, D. CXC Chemokine Ligand 9/Monokine Induced by IFN- Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors. The Journal of Immunology. 2007-02-15, roč. 178, čís. 4, s. 2278–2286. Dostupné online [cit. 2019-04-30]. ISSN0022-1767. doi:10.4049/jimmunol.178.4.2278. (anglicky)
ZOHAR, Yaniv; WILDBAUM, Gizi; NOVAK, Rostislav. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. Journal of Clinical Investigation. 2014-05-01, roč. 124, čís. 5, s. 2009–2022. Dostupné online [cit. 2019-04-30]. ISSN0021-9738. doi:10.1172/JCI71951. PMID24713654. (anglicky)
MOSSER, David M.; EDWARDS, Justin P. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 2008-12, roč. 8, čís. 12, s. 958–969. Dostupné online [cit. 2019-04-30]. ISSN1474-1733. doi:10.1038/nri2448. PMID19029990. (anglicky)
BEDOGNETTI, D; SPIVEY, T L; ZHAO, Y. CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. British Journal of Cancer. 2013-10, roč. 109, čís. 9, s. 2412–2423. Dostupné online [cit. 2019-04-30]. ISSN0007-0920. doi:10.1038/bjc.2013.557. PMID24129241. (anglicky)